Company Encyclopedia
View More
name
Klotho Neurosciences
KLTO.US
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer’s disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig’s disease. The company was formerly known as Anew Medical, Inc.
1.935 T
KLTO.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Klotho Neurosciences | 10-Q: FY2025 Q3 Revenue: USD 0

    LB filings·
    US
    KLTO
    -4.75%
    LB filings·
    US
    KLTO
    -4.75%

    Klotho Neurosciences | 10-Q: FY2025 Q2 EPS: USD -0.12

    LB filings·
    US
    KLTO
    -4.75%
    LB filings·
    US
    KLTO
    -4.75%

    Pre-market hot trades in US stocks: Klotho Neurosciences pre-market down 7.69%

    Klotho Neurosciences pre-market down 7.69%; Sonnet BioTherapeutics pre-market up 321.66%; OceanPal pre-market up 88.97%; Click Holdings/BVI pre-market up 45.78%

    Tracking Unusual Activity·
    US
    KLTO
    -4.75%
    Tracking Unusual Activity·
    US
    KLTO
    -4.75%

    U.S. stock market update: Klotho Neurosciences down 7.50%

    Klotho Neurosciences fell 7.50%; MiNK Therapeutics rose 624.84%, with a transaction volume of USD 1.01 billion; AbbVie fell 1.35%, with a transaction volume of USD 405 million; Gilead Sciences fell 3.29%, with a transaction volume of USD 278 million; Amgen fell 1.77%, with a market value of USD 158.7 billion

    Tracking Unusual Activity·
    US
    KLTO
    -4.75%
    Tracking Unusual Activity·
    US
    KLTO
    -4.75%

    Pre-market hot trades in US stocks: Klotho Neurosciences pre-market down 8.90%; AIRO pre-market up 8.51%

    Klotho Neurosciences pre-market down 8.90%; AIRO pre-market up 8.51%; Above Food Ingredients pre-market up 142.58%; BTC Digital pre-market up 45.60%; Future Fintech pre-market up 44.37%

    Tracking Unusual Activity·
    US
    KLTO
    -4.75%
    US
    AIRO
    -6.52%
    US
    ABVE
    -7.42%
    Tracking Unusual Activity·
    US
    KLTO
    -4.75%
    US
    AIRO
    -6.52%
    US
    ABVE
    -7.42%
    © 2025 Longbridge｜Disclaimer